| Part of a series on |
| Cannabis |
|---|
 |
Michael Alan Krawitz is a US Air force veteran,[1] Executive Director of the non-profit Veterans for Medical Cannabis Access,[2] researcher on the history of medical cannabis, and international advocate for cannabis policy reform[3] with FAAAT think & do tank and the International Association for Cannabinoid Medicines.[4]
YouTube Encyclopedic
-
1/5Views:4604 3664454131 963
-
Veterans & Cannabis @ Cannabis Science Conference
-
Peter Robinson, M.D. - Exome Sequencing
-
Chloe Tartan - Research Scientist at Nchain - Conversation #22 with the Women of BSV
-
Ep.#90: Hume AI’s Emotionally Intelligent AI, Rise of AI Journalists, & Claude 3 Opus Beats GPT-4
-
Crowdsourcing Medicine: Barbara Prainsack at TEDxSalzburg
Transcription
Biography
Krawitz served in the United States Air Force from 1981 to 1986 as an Electronic Warfare Systems Technician and was a sergeant.[1] He was stationed in Guam.
Apart from his military career, Krawitz has been involved in the United States,[5] researching the traditions and historicity of cannabis in the country,[6] as well as working to secure access and availability of medical cannabis[7] for veterans,[8] in particular with the United States Department of Veterans Affairs[9][10] and has extended its involvement at the international level since the United Nations General Assembly Special Session on the world drug situation in 1998 throughout the 2020s.[11]
Internationally he has been involved in the New-York NGO Committee on Drugs as Executive Committee member,[12] as patient representative of the International Association for Cannabinoid Medicines.[4] Krawitz is also policy adviser of the organization FAAAT think & do tank[13] for his involvement around the World Health Organization[14][15][16] and Single Convention on Narcotic Drugs international scheduling of Cannabis,[17][18] being instrumental in the efforts leading to the withdrawal of "cannabis and cannabis resin" from Schedule IV of the 1961 Convention, in December 2020.[19][20][21][22]
Krawitz is also working on the creation of Appellation of Origin and other intellectual property tools for traditional Cannabis products,[23] both in the United States, participating as a board member of the Californian farmers organization Origins Council,[24] and internationally as a registered observer to the World Intellectual Property Organization.[25]
Since 2021, he has been member of board of advisors to the Virginia Cannabis Control Authority (Cannabis Public Health Advisory Council).[26]
Publications
- Mathre, Mary; Krawitz, Michael (2002). "Cannabis series-the whole story Part 4: The medicinal use of Cannabis pre-prohibition". Drugs, Habits and Social Policy. 2 (2): 3–7. doi:10.1108/17459265200200010.
- Wirtshafter, Don; Krawitz, Michael A. (2006). "Hemp Stamps Bring Record Prices". Journal of Industrial Hemp. 10 (2): 67–74. doi:10.1300/J237v10n02_06. S2CID 154651330.
- Krawitz, Michael A. (2006). "Parke, Davis Marketed Cannabis Extracts To Doctors With 'Buy American' Pitch" (PDF). O'Shaughnessy's. Spring 2006. Society of Cannabis Clinicians: 4–5.
- Krawitz, Michael (2007). "Collectible Cannabis Art". Journal of Industrial Hemp. 12 (1): 47–54. doi:10.1300/J237v12n01_05. S2CID 87278546.
- Krawitz, Michael (2008). "Nostrums, Quackery, and Visions of Grandeur". Journal of Industrial Hemp. 13 (2): 171–175. doi:10.1080/15377880802393171. S2CID 85310390.
- Krawitz, Michael (2015) [2015]. Statement of Michael Krawitz as delivered to the World Health Organization, Expert Committee on Drug Dependence (PDF) (Speech). 38th meeting of the World Health Organization's Expert Committee on Drug Dependence, November 2015. Expert Committee on Drug Dependence, Open session contribution. Geneva, Switzerland: World Health Organization (published December 2015). Archived from the original (PDF) on March 24, 2022.
- Krawitz, Michael (2015). "Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates". AMA Journal of Ethics. 17 (6): 558–561. doi:10.1001/journalofethics.2015.17.6.pfor2-1506. PMID 26075984.
- Riboulet-Zemouli, Kenzi; Krawitz, Michael A.; Ghehiouèche, Farid (2018). The Crimson Digest (Vol. 1), Briefing on the international scientific assessment of Cannabis: Processes, stakeholders and history. Paris, France: FAAAT editions. ISBN 979-10-97087-06-7.
- Riboulet-Zemouli, Kenzi; Krawitz, Michael A.; Ghehiouèche, Farid (2021). History, Science, and Politics of International Cannabis Scheduling, 2015–2021. Vienna, Austria: FAAAT editions. ISBN 979-10-97087-50-0.
- Riboulet-Zemouli, Kenzi; Krawitz, Michael A. (2022). "WHO's first scientific review of medicinal Cannabis: from global struggle to patient implications" (PDF). Drugs, Habits and Social Policy. 23 (1): 5–21. doi:10.1108/DHS-11-2021-0060. S2CID 247421561.
References
- ^ a b Rick Schettino (August 12, 2018). "Michael Krawitz leaves no soldier behind: The Executive Director of Veterans for Medical Cannabis Access on VA and federal marijuana policies". Pot Network. Retrieved February 8, 2019.
- ^ Bryce Crawford (July 29, 2010). "MMJ believers embrace Veterans Affairs' new stance". Colorado Springs Independent. Retrieved February 7, 2019.
- ^ "The High Times Interview: Michael Krawitz". High Times. January 2, 2015. Retrieved February 25, 2022.
- ^ a b Grotenhermen, Franjo; Müller-Vahl, Kirsten R. (April 15, 2021). "Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids". Cannabis and Cannabinoid Research. 6 (2): 82–87. doi:10.1089/can.2020.0044. ISSN 2578-5125. PMC 8064956. PMID 33912675.
- ^ "Veterans are key as surge of states OK medical pot for PTSD". The Washington Times. Associated Press. November 26, 2017. Retrieved February 8, 2019.
- ^ Mary Mathre & Michael Krawitz (2012). "Cannabis series - the whole story Part 4: The medicinal use of Cannabis pre-prohibition". Drugs and Alcohol Today. 2 (2): 3–7. doi:10.1108/17459265200200010.
- ^ Cal Woodward (September 21, 2010). "United States war veterans gain access to medicinal marijuana. CMAJ September 21, 2010 182 (13) 1405–1406; DOI: doi.org/10.1503/cmaj.109-3334". Canadian Medical Association Journal. 182 (13): 1405–6. doi:10.1503/cmaj.109-3334. PMC 2942910. PMID 20713581.
- ^ Ocean Malandra (February 4, 2019). "Cannabis Provides Relief for Vets, Assault Victims With PTSD". Weedmaps News. Retrieved February 8, 2019.
- ^ Dan Frosch (July 23, 2010). "V.A. Easing Rules for Users of Medical Marijuana". The New York Times. Retrieved February 7, 2019.
- ^ Michael Krawitz (June 17, 2015). "Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates". AMA Journal of Ethics. 17 (6): 558–61. doi:10.1001/journalofethics.2015.17.6.pfor2-1506. PMID 26075984. Retrieved February 8, 2019.
- ^ International Association for Cannabinoid Medicines (March 16, 2022). "IACM on LinkedIn: Today the IACM Patient Council had the opportunity to share their work and debate about the actual situation in UN - CND (United Nations Commission on Narcotic Drugs)". www.linkedin.com. Retrieved March 24, 2022.
- ^ New York NGO Committee on Drugs (2016). "Collection of member organization submissions to UNGASS" (PDF). United Nations Office on Drugs and Crime. Retrieved February 8, 2019.
- ^ Susan Mayor (February 5, 2019). "WHO proposes rescheduling cannabis to allow medical applications". British Medical Journal. 364: l574. doi:10.1136/bmj.l574. PMID 30723076. S2CID 73449383. Retrieved February 7, 2019.
- ^ Michael Krawitz (November 16, 2015). "Statement of Michael Krawitz as delivered to the World Health Organization, Expert Committee on Drug Dependence, 16 November 2015" (PDF). World Health Organization. Retrieved February 8, 2019.
- ^ Aristos Georgiou (February 8, 2019). "WHO RECOMMENDS RESCHEDULING CANNABIS IN INTERNATIONAL LAW FOR FIRST TIME IN HISTORY". Newsweek. Retrieved February 9, 2019.
- ^ Riboulet-Zemouli, Kenzi; Krawitz, Michael Alan (January 1, 2022). "WHO's first scientific review of medicinal Cannabis: from global struggle to patient implications". Drugs, Habits and Social Policy. 23: 5–21. doi:10.1108/DHS-11-2021-0060. ISSN 2752-6747. S2CID 247421561.
- ^ Tom Angell (February 1, 2019). "World Health Organization Recommends Reclassifying Marijuana Under International Treaties". Forbes. Retrieved February 7, 2019.
- ^ Redaction (February 1, 2019). "OMS quer classificação mais branda para maconha em tratados internacionais". Globo. Retrieved February 8, 2019.
- ^ Isabella Kwai (December 2, 2020). "U.N. Reclassifies Cannabis as a Less Dangerous Drug". New York Times. Retrieved December 2, 2020.
- ^ Robert Hoban (December 3, 2020). "The United Nations Reclassifies Cannabis Clearing Path For Global Industry". Forbes. Retrieved December 5, 2020.
- ^ Budryk, Zack (December 2, 2020). "United Nations commission votes to remove marijuana from list of most dangerous drugs". The Hill.
- ^ Riboulet-Zemouli, Kenzi; Krawitz, Michael; Ghehiouèche, Farid (2021). History, science, and politics of international cannabis scheduling, 2015–2021. Vienna: FAAAT editions. ISBN 979-10-97087-50-0.
- ^ "The Importance of Appellations of Origin to the Successful Therapeutic Model of Whole Plant Cannabis". ICFA Programs > Advocacy. International Cannabis farmers Association. Retrieved July 27, 2020.
- ^ "About Us". Origins Council. Retrieved July 27, 2020.
- ^ "REPORT adopted by the Committee" (PDF). WIPO Committee on Development and Intellectual Property (CDIP). Twenty-Third Session. Geneva. May 20–24, 2019. Retrieved July 27, 2020.
- ^ Cannabis Control Authority, Board of Directors. "Meeting - MINUTES - Dec. 8, 2021". studies.virginiageneralassembly.gov. Retrieved February 25, 2022.
External links
- Veterans for Medical Cannabis Access website.
- FAAAT think & do tank website.
- Michael Krawitz on ResearchGate
This page was last edited on 7 April 2024, at 09:52